Inotiv Inc
NASDAQ:NOTV

Watchlist Manager
Inotiv Inc Logo
Inotiv Inc
NASDAQ:NOTV
Watchlist
Price: 0.5527 USD 1.94% Market Closed
Market Cap: 19m USD

Operating Margin

-6.8%
Current
Declining
by 2.3%
vs 3-y average of -4.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.8%
=
Operating Income
$-34.7m
/
Revenue
$513m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.8%
=
Operating Income
$-34.7m
/
Revenue
$513m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Inotiv Inc
NASDAQ:NOTV
19m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
171B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.9B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
281.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 71% of companies in the United States of America
Percentile
29th
Based on 14 112 companies
29th percentile
-6.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Inotiv Inc
Glance View

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company is headquartered in West Lafayette, Indiana and currently employs 541 full-time employees. The firm focuses on providing drug developers with scientific research and analytical instrumentation. The firm operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

NOTV Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-6.8%
=
Operating Income
$-34.7m
/
Revenue
$513m
What is Inotiv Inc's current Operating Margin?

The current Operating Margin for Inotiv Inc is -6.8%, which is below its 3-year median of -4.5%.

How has Operating Margin changed over time?

Over the last 3 years, Inotiv Inc’s Operating Margin has decreased from 4.7% to -6.8%. During this period, it reached a low of -12.3% on Dec 31, 2024 and a high of 4.7% on Sep 30, 2022.

Back to Top